This HTML5 document contains 171 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n10http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n13https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q55416802
rdf:type
wikibase:Item
schema:description
vedecký článok научная статья سائنسی مضمون ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2018年学术文章 2018년 논문 мақолаи илмӣ tudományos cikk wetenschappelijk artikel articol științific научни чланак wissenschaftlicher Artikel artikull shkencor article científic tieteellinen artikkeli artigo científico (publicado na 2018) مقالهٔ علمی articolo scientifico vědecký článek επιστημονικό άρθρο article scientifique (publié 2018) 2018年学术文章 2018年の論文 bài báo khoa học 2018年學術文章 научна статия videnskabelig artikel (udgivet 2018) artículu científicu scienca artikolo სამეცნიერო სტატია 2018年学术文章 artigo científico 2018年學術文章 мақолаи илмӣ مقالة علمية mokslinis straipsnis 2018年學術文章 บทความทางวิทยาศาสตร์ artykuł naukowy מאמר מדעי 2018年學術文章 գիտական հոդված vetenskaplig artikel bilimsel makale article scientific 2018 nî lūn-bûn artikulong pang-agham наукова стаття, опублікована у квітні 2018 vitenskapelig artikkel artículo científico publicado en 2018 научни чланак artigo científico (publicado na 2018) naučni članak 2018年学术文章 2018年學術文章 scientific article teaduslik artikkel 2018年学术文章 vitskapeleg artikkel 2018年學術文章
p:P577
wds:Q55416802-A4689450-6CB0-4859-8531-D055782D84B0
wdt:P577
2018-04-05T00:00:00Z
p:P2888
wds:Q55416802-D4992837-D7F3-4448-99A5-B5E4998D1FF6
wdt:P2888
n13:s11419-018-0413-1
p:P2860
wds:Q55416802-3EA34164-B805-4064-88A1-45D1A6C7E1DB wds:Q55416802-227334D3-D882-400D-A672-A581E123639A wds:Q55416802-23A3F63F-72EF-438E-9CC2-88F5A76AEC3F wds:Q55416802-5AD3A91B-02B6-4FA2-B921-3CCC1F4278D9 wds:Q55416802-5DC8DC45-B8CC-44FC-93DD-4530D98D0398 wds:Q55416802-6040C0A1-7CD5-45DE-BEA9-C5B4E496D9B0 wds:Q55416802-41B0AE76-C430-42E3-A281-EBB7122B4185 wds:Q55416802-41D6C687-DCAF-4CD9-9528-B8E321577695 wds:Q55416802-42FE70EF-040D-445F-B9FB-7838FA847379 wds:Q55416802-43B9325C-378F-4B9C-8F2B-259532AC6D4B wds:Q55416802-05270DE3-1C41-4946-9181-6B701622DE29 wds:Q55416802-124B0AC5-E744-4E68-93E4-F658B1015D41 wds:Q55416802-DB73F62D-DDE7-48DF-B553-AE576909BC82 wds:Q55416802-DEDDFECA-D85C-4EA7-AAB9-8485F396BC91 wds:Q55416802-C0DF5E67-1649-4921-A882-CC0B7F97C267 wds:Q55416802-C0F3ADA2-0093-451B-BFE6-45F42592543F wds:Q55416802-D1003158-4393-4297-97E5-2886E3A4A12D wds:Q55416802-E3B4482B-182B-47FE-BCAC-5A749D918FC7 wds:Q55416802-FE8D7E2E-C4B4-41C3-94EA-88129CED38EB wds:Q55416802-7EE5F9B6-0564-4C1B-81D9-304E4665B0BE wds:Q55416802-95C9E2DA-250C-45F4-A8BA-78C393ED9253 wds:Q55416802-61C9A256-1B04-4C1C-965B-D8E197528B46 wds:Q55416802-7682333D-D8A4-4B87-8B72-D21C25904C9D
wdt:P2860
wd:Q44341980 wd:Q44336586 wd:Q34471511 wd:Q34255338 wd:Q28340709 wd:Q38637508 wd:Q30491920 wd:Q48176056 wd:Q34186688 wd:Q33857373 wd:Q40179740 wd:Q50645645 wd:Q48348504 wd:Q38792388 wd:Q49556857 wd:Q34608510 wd:Q53111860 wd:Q43977082 wd:Q38732154 wd:Q39173651 wd:Q51137768 wd:Q34436183 wd:Q44061215
p:P2093
wds:Q55416802-25C09EC1-C219-4E78-87E2-22D37DFD3A2C wds:Q55416802-31510A49-9609-4957-8C20-52252CEDC9D4 wds:Q55416802-869E7243-2EC8-43D6-B10E-104E35E796E2 wds:Q55416802-BDFF989B-EBF8-4FED-BE79-F745539B6959 wds:Q55416802-B929E848-D819-49AB-91C5-3D428DFA1743 wds:Q55416802-D18164A7-5F3C-40B5-98FA-975815B94B49
wdt:P2093
Paul Scullion Daniel Fletcher Kevin D Read Lysbeth H Antonides Ola Epemolu Alexia Rylski
rdfs:label
Chemical synthesis, characterisation and in vitro and in vivo metabolism of the synthetic opioid MT-45 and its newly identified fluorinated analogue 2F-MT-45 with metabolite confirmation in urine samples from known drug users. Chemical synthesis, characterisation and in vitro and in vivo metabolism of the synthetic opioid MT-45 and its newly identified fluorinated analogue 2F-MT-45 with metabolite confirmation in urine samples from known drug users.
skos:prefLabel
Chemical synthesis, characterisation and in vitro and in vivo metabolism of the synthetic opioid MT-45 and its newly identified fluorinated analogue 2F-MT-45 with metabolite confirmation in urine samples from known drug users. Chemical synthesis, characterisation and in vitro and in vivo metabolism of the synthetic opioid MT-45 and its newly identified fluorinated analogue 2F-MT-45 with metabolite confirmation in urine samples from known drug users.
schema:name
Chemical synthesis, characterisation and in vitro and in vivo metabolism of the synthetic opioid MT-45 and its newly identified fluorinated analogue 2F-MT-45 with metabolite confirmation in urine samples from known drug users. Chemical synthesis, characterisation and in vitro and in vivo metabolism of the synthetic opioid MT-45 and its newly identified fluorinated analogue 2F-MT-45 with metabolite confirmation in urine samples from known drug users.
p:P50
wds:Q55416802-E464B4F2-4557-4461-8BF9-BE5326D67BA2 wds:Q55416802-FDF715C8-72A2-4DB9-80CB-FBF07D9A9C55 wds:Q55416802-1FBEC167-3664-478F-9307-94CF7B8BD648 wds:Q55416802-B31D562A-2932-499A-8664-68889E3CC38A wds:Q55416802-B7B985C8-3E1D-4589-85F3-33BCD047E315 wds:Q55416802-7950843F-33EB-43CB-A689-AEDEBC0DC063 wds:Q55416802-12CE8F20-D2F5-4CEB-B2F5-AD58F1D075E3
wdt:P50
wd:Q52660514 wd:Q57635587 wd:Q56419809 wd:Q39064791 wd:Q107983390 wd:Q96093729 wd:Q56380900
p:P1476
wds:Q55416802-B292FB40-8A77-44E2-88DF-7365B993163C
wdt:P1476
Chemical synthesis, characterisation and in vitro and in vivo metabolism of the synthetic opioid MT-45 and its newly identified fluorinated analogue 2F-MT-45 with metabolite confirmation in urine samples from known drug users.
p:P304
wds:Q55416802-BC7AC7DE-1290-4F16-936C-44D22841005F
wdt:P304
359-374
p:P31
wds:Q55416802-E21AF3B9-9459-40B3-9BB6-2520C41AB57C
wdt:P31
wd:Q13442814
p:P921
wds:Q55416802-be5f6732-f343-4007-b076-4a33b1c6c0dd
wdt:P921
wd:Q427523
p:P698
wds:Q55416802-17F05AF5-9C38-42BC-99DE-ED46E3EC2672
wdtn:P698
n9:29963206
wdt:P698
29963206
p:P1433
wds:Q55416802-615941CB-9FDD-4E5F-A39E-04B2E063C428
wdt:P1433
wd:Q15724497
p:P433
wds:Q55416802-5758AB64-CCB6-4738-A918-9335E55D2BD7
p:P478
wds:Q55416802-4182C96F-B3DB-40C2-9F42-CC85EA4AD01D
wdt:P433
2
wdt:P478
36
p:P356
wds:Q55416802-2889ABC1-9534-4796-BFC4-AFCCE684084A
wdtn:P356
n10:S11419-018-0413-1
wdt:P356
10.1007/S11419-018-0413-1
p:P275
wds:Q55416802-ba45e23f-719b-4591-b6fd-962ba6c8405b
p:P6216
wds:Q55416802-c82e4096-2a62-47db-b6a0-9054557f6b23
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863
p:P6179
wds:Q55416802-65D62291-A771-438B-9CAA-0D3009AC05E9
wdt:P6179
1103160997
p:P932
wds:Q55416802-A3471B7A-AC28-4DFC-B5B2-F8748F41E8CD
wdt:P932
6002428